ºÐÀÚ ½ºÀ§Ä¡ ½ÃÀå : Ä¡·á Ç¥Àû, ÀǾàǰ °³¹ß, ¾à¹°Àü´Þ ¸ÞÄ¿´ÏÁò-ÀûÀÀÁõº° ¿ëµµ(2025³â)
Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025
»óǰÄÚµå : 1627538
¸®¼­Ä¡»ç : KuicK Research
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,300 £Ü 4,774,000
PDF (Single User License) help
º¸°í¼­ PDF¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ¸¸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,600 £Ü 9,549,000
PDF (Multi-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ºÐÀÚ ½ºÀ§Ä¡´Â ƯÁ¤ ȯ°æ ¶Ç´Â »ý¹°ÇÐÀû Æ®¸®°Å¿¡ ¹ÝÀÀÇÏ¿© ¼­·Î ´Ù¸¥ »óÅ »çÀ̸¦ Àüȯ ÇÒ ¼ö ÀÖ´Â µ¿Àû Á¸ÀçÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Æ®¸®°Å¿¡´Â pH º¯È­, ±¤Á¶»ç, ¿Âµµ, »êÈ­ ȯ¿ø Á¶°Ç, ƯÁ¤ ÀÌ¿ÂÀ̳ª »ýü ºÐÀÚÀÇ Á¸Àç µîÀÌ Æ÷ÇԵ˴ϴÙ. ºÐÀÚ ½ºÀ§Äª °³³äÀº °íµµ·Î Á¦¾îµÈ Áø´Ü ¹× Ä¡·á ½Ã½ºÅÛÀÇ ±â¹ÝÀ» Á¦°øÇÔÀ¸·Î½á ÀÇ·á ¹× Á¦¾à ºÐ¾ß¿¡ Å« ¿µÇâÀ» ¹ÌÃÄ ¿Ô½À´Ï´Ù. »ý¹°ÇÐÀû ¹ÝÀÀÀ» Á¤È®ÇÏ°Ô Á¦¾îÇÏ´Â ´É·Â¿¡ ÀÇÇØ ºÐÀÚ ½ºÀ§Ä¡´Â °íµµÀÇ ¾à¹° Àü´Þ ½Ã½ºÅÛ, ½Ç½Ã°£ Áø´Ü Åø, °³º°È­ Ä¡·á °³ÀÔÀÇ °³¹ß¿¡ ºÒ°¡°áÇÑ °ÍÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÀǾàǰ ºÐ¾ß¿¡¼­ ºÐÀÚ ½ºÀ§Ä¡´Â ÀǾàǰ Ȱ¼º ¼ººÐÀÇ ¹æÃâÀ» ½Ã°ø°£ÀûÀ¸·Î Á¤È®ÇÏ°Ô Á¦¾îÇÒ ¼ö ÀÖ°Ô Çϰí, ¾à¹° Àü´Þ¿¡ Çõ¸íÀ» °¡Á®¿Ô½À´Ï´Ù. pH °¨¼ö¼º ºÐÀÚ ½ºÀ§Ä¡´Â ³ª³ë ÀÔÀÚ ±â¹Ý ¾à¹° ij¸®¾î¿¡ äÅõǾî ÀÖÀ¸¸ç, Åë»óÀûÀÎ »ý¸®Àû Á¶°Ç ÇÏ¿¡¼­´Â ¾ÈÁ¤¼ºÀ» À¯ÁöÇÏÁö¸¸ »ê¼º ȯ°æ¿¡¼­´Â ºÐÇØµÇ¾î ÆäÀ̷ε带 ¹æÃâÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, FPBC@SN ³ª³ëÀÔÀÚ ½Ã½ºÅÛÀº À¯¹æ¾Ï ¼¼Æ÷ÀÇ »ê¼º ¼¼Æ÷ÁúÀ» Ç¥ÀûÀ¸·Î ÇÏ´Â pH °¨¼ö¼º ºÐÀÚ ½ºÀ§Ä¡¸¦ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº Æä·ÓÅͽýº¸¦ À¯µµÇÏ´Â ¼Ö¶óÆä´Õ°ú Á¾¾ç ¸é¿ªÀ» Áõ°­ÇÏ´Â IDO ÀúÇØÁ¦¸¦ ¸ðµÎ ¹æÃâÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½ºÀ§Ä¡¸¦ Ȱ¿ëÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ¿ÀÇÁ Ÿ°Ù È¿°ú¸¦ ÁÙÀ̰í Ä¡·á Áö¼ö¸¦ ³ôÀ̸ç Á¾¾çÇÐÀÇ Áß¿äÇÑ °úÁ¦¿¡ ´ëóÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ ºÐÀÚ ½ºÀ§Ä¡ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ºÐÀÚ ½ºÀ§Ä¡ÀÇ Ä¡·á Ç¥ÀûÀ¸·Î¼­ÀÇ Á߿伺, ºÎ¹®º° µ¿Çâ, ½Å±â¼ú°ú ÇâÈÄ Àü¸Á µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐÀÚ ½ºÀ§Ä¡ÀÇ ¼­¹®

Á¦2Àå ºÐÀÚ ½ºÀ§Ä¡ÀÇ ÀÇÇÐÀû ÀǹÌ

Á¦3Àå ¾à¹° Àü´Þ ¹× ¹æÃâ¿¡¼­ ºÐÀÚ ½ºÀ§Ä¡ÀÇ Á߿伺

Á¦4Àå ºÐÀÚ ½ºÀ§Ä¡ÀÇ Ä¡·á Ç¥ÀûÀ¸·Î¼­ÀÇ Á߿伺

Á¦5Àå ºÐÀÚ ½ºÀ§Ä¡-´ëºÐ·ù

Á¦6Àå ºÐÀÚ ½ºÀ§Ä¡ : ¾Ï ÀûÀÀº°

Á¦7Àå ºÐÀÚ ½ºÀ§Ä¡: ½Å°æ Áúȯº°

Á¦8Àå ºÐÀÚ ½ºÀ§Ä¡ : °¨¿°Áõº°

Á¦9Àå ºÐÀÚ ½ºÀ§Ä¡ : ÀÚ°¡¸é¿ªÁúȯ ¹× ¿°Áõ¼ºÁúȯº°

Á¦10Àå ºÐÀÚ ½ºÀ§Ä¡ : ½ÉÇ÷°ü Áúȯº°

Á¦11Àå Àç»ý ÀÇ·á¿¡¼­ÀÇ ºÐÀÚ ½ºÀ§Ä¡ÀÇ Á߿伺

Á¦12Àå ºÐÀÚ ½ºÀ§Ä¡¸¦ Ç¥ÀûÀ¸·Î ÇÑ ÁÖ¿ä ÀǾàǰÀÇ ÆÇ¸Å µ¿Çâ

Á¦13Àå ÀǾàǰ ó¹æ¿¡¼­ ºÐÀÚ ½ºÀ§Ä¡

Á¦14Àå ÇöÀçÀÇ µ¿Çâ ¹× ½Å±â¼ú

Á¦15Àå ¹Ì·¡ÀÇ Àü¸Á ¹× ¹æÇ⼺

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025 Research Insights:

Molecular switches are dynamic entities capable of transitioning between distinct states in response to specific environmental or biological triggers. These triggers can include changes in pH, light exposure, temperature, redox conditions, or the presence of certain ions or biomolecules. The concept of molecular switching has significantly influenced the medical and pharmaceutical domain by providing a foundation for highly controlled diagnostic and therapeutic systems. The ability to precisely regulate biological responses has made molecular switches indispensable in the development of advanced drug delivery systems, real-time diagnostic tools, and personalized therapeutic interventions.

In the pharmaceutical sector, molecular switches have revolutionized drug delivery by enabling precise spatiotemporal control over the release of active pharmaceutical ingredients. One of the most widely explored triggers is pH, as pathological conditions like cancer and inflammation often create acidic microenvironments. pH-sensitive molecular switches are employed in nanoparticle-based drug carriers, which remain stable under normal physiological conditions but disassemble in acidic environments to release their payload. For example, the FPBC@SN nanoparticle system integrates a pH-sensitive molecular switch to target acidic cytoplasm in breast cancer cells. This system releases both sorafenib, which induces ferroptosis, and an IDO inhibitor to enhance tumor immunity. By leveraging such switches, these systems reduce off-target effects and enhance the therapeutic index, addressing key challenges in oncology.

Table of Contents

1. Introduction To Molecular Switches

2. Molecular Switches Clinical Significance In Medicine

3. Molecular Switches Significance In Drug Delivery & Release

4. Molecular Switches Significance As Therapeutic Targets

5. Molecular Switches - Broad Classification

6. Molecular Switches By Cancer Indication

7. Molecular Switches By Neurological Disorder

8. Molecular Switches By Infectious Disease

9. Molecular Switches By Autoimmune & Inflammatory Disorder

10. Molecular Switches By Cardiovascular Disease

11. Molecular Switches Significance In Regenerative Medicine

12. Sales Insight Of Key Drugs Targeting Molecular Switches

13. Molecular Switches In Drug Formulation

14. Current Trends & Emerging Technologies

15. Future Perspectives & Directions

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â